$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-K Financial Statement

#000139681417000009 Filed on March 01, 2017

Income Statement

Concept	2016 Q4	2015 Q4	2015 Q3
Revenue	$72.90M	$69.32M	$62.21M
YoY Change	5.17%	-64.93%	19.53%
Cost Of Revenue	$23.62M	$19.43M	$15.90M
YoY Change	21.59%	-74.91%	-22.02%
Gross Profit	$49.28M	$49.89M	$46.31M
YoY Change	-1.23%	-58.5%	46.29%
Gross Profit Margin	67.6%	71.97%	74.44%
Selling, General & Admin	$34.70M	$37.60M	$35.31M
YoY Change	-7.71%	-64.75%	25.14%
% of Gross Profit	70.41%	75.36%	76.24%
Research & Development	$17.10M	$13.20M	$5.893M
YoY Change	29.55%	-29.53%	33.18%
% of Gross Profit	34.7%	26.46%	12.72%
Depreciation & Amortization	$3.260M	$3.120M	$2.800M
YoY Change	4.49%	-68.91%	21.74%
% of Gross Profit	6.62%	6.25%	6.05%
Operating Expenses	$75.36M	$70.13M	$57.10M
YoY Change	7.46%	-65.42%	7.68%
Operating Profit	-$26.08M	-$20.24M	$5.109M
YoY Change	28.86%	291.87%	-618.68%
Interest Expense	-$1.500M	-$1.700M	$1.905M
YoY Change	-11.76%	-120.54%	-6.48%
% of Operating Profit			37.29%
Other Income/Expense, Net	-$100.0K	-$100.0K	-$1.742M
YoY Change	0.0%	-98.81%	-13.72%
Pretax Income	-$4.000M	-$2.600M	$3.367M
YoY Change	53.85%	-80.8%	-212.08%
Income Tax	$0.00	-$100.0K	$281.0K
% Of Pretax Income			8.35%
Net Earnings	-$3.973M	-$2.498M	$3.086M
YoY Change	59.05%	-81.79%	-202.73%
Net Earnings / Revenue	-5.45%	-3.6%	4.96%
Basic Earnings Per Share			$0.08
Diluted Earnings Per Share	-$107.0K	-$67.93K	$0.08
COMMON SHARES
Basic Shares Outstanding	37.40M shares	36.76M shares	36.66M shares
Diluted Shares Outstanding			41.04M shares

Balance Sheet

Concept	2016 Q4	2015 Q4	2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$172.6M	$159.0M	$146.4M
YoY Change	8.55%	1.47%	-2.2%
Cash & Equivalents	$35.94M	$54.13M	$30.52M
Short-Term Investments	$136.7M	$102.0M	$115.9M
Other Short-Term Assets	$9.300M	$6.100M	$4.600M
YoY Change	52.46%	1.67%	-13.21%
Inventory	$31.28M	$61.65M	$56.13M
Prepaid Expenses
Receivables	$29.94M	$25.86M	$25.92M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$243.1M	$252.6M	$233.1M
YoY Change	-3.76%	17.89%	16.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$101.0M	$90.32M	$86.32M
YoY Change	11.84%	48.97%	53.74%
Goodwill	$46.74M	$30.88M	$28.89M
YoY Change	51.35%	29.96%	31.02%
Intangibles
YoY Change
Long-Term Investments	$0.00	$13.50M	$17.90M
YoY Change	-100.0%	-44.67%	-26.94%
Other Assets	$624.0K	$406.0K	$2.595M
YoY Change	53.69%	-84.31%	-11.97%
Total Long-Term Assets	$148.4M	$135.2M	$135.9M
YoY Change	9.78%	20.87%	28.01%
TOTAL ASSETS
Total Short-Term Assets	$243.1M	$252.6M	$233.1M
Total Long-Term Assets	$148.4M	$135.2M	$135.9M
Total Assets	$391.5M	$387.7M	$369.0M
YoY Change	0.96%	18.91%	20.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.511M	$8.739M	$8.471M
YoY Change	-14.05%	29.31%	9.35%
Accrued Expenses	$36.67M	$35.38M	$30.30M
YoY Change	3.65%	24.95%	29.56%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$104.0M	$104.9M
YoY Change	-100.0%	0.87%	2.74%
Long-Term Debt Due	$118.5M	$118.5M	$0.00
YoY Change	0.0%	-1.22%	-100.0%
Total Short-Term Liabilities	$44.84M	$149.8M	$145.4M
YoY Change	-70.07%	6.98%	7.53%
LONG-TERM LIABILITIES
Long-Term Debt	$108.7M	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$18.91M	$11.47M	$6.125M
YoY Change	64.86%	112.11%	17.0%
Total Long-Term Liabilities	$18.91M	$11.47M	$6.125M
YoY Change	64.86%	112.11%	17.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$44.84M	$149.8M	$145.4M
Total Long-Term Liabilities	$18.91M	$11.47M	$6.125M
Total Liabilities	$172.5M	$169.3M	$160.0M
YoY Change	1.86%	9.31%	6.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$346.2M	-$308.3M	-$305.8M
YoY Change	12.31%	-0.6%	-3.21%
Common Stock	$37.00K	$37.00K	$37.00K
YoY Change	0.0%	2.78%	2.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	0.000 shares	0.000 shares	0.000 shares
Shareholders Equity	$219.0M	$218.4M	$209.0M
YoY Change
Total Liabilities & Shareholders Equity	$391.5M	$387.7M	$369.0M
YoY Change	0.96%	18.91%	20.82%

Cashflow Statement

Concept	2016 Q4	2015 Q4	2015 Q3
OPERATING ACTIVITIES
Net Income	-$3.973M	-$2.498M	$3.086M
YoY Change	59.05%	-81.79%	-202.73%
Depreciation, Depletion And Amortization	$3.260M	$3.120M	$2.800M
YoY Change	4.49%	-68.91%	21.74%
Cash From Operating Activities	$17.35M	$16.06M	$2.820M
YoY Change	8.03%	13.9%	-68.6%
INVESTING ACTIVITIES
Capital Expenditures	-$4.880M	-$8.150M	-$9.610M
YoY Change	-40.12%	-135.46%	94.14%
Acquisitions
YoY Change
Other Investing Activities	-$2.040M	$16.38M	$2.760M
YoY Change	-112.45%	47.17%	-102.85%
Cash From Investing Activities	-$6.910M	$8.230M	-$6.840M
YoY Change	-183.96%	180.89%	-93.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.070M	2.170M	1.830M
YoY Change	-50.69%	-20.8%	-23.11%
NET CHANGE
Cash From Operating Activities	17.35M	16.06M	2.820M
Cash From Investing Activities	-6.910M	8.230M	-6.840M
Cash From Financing Activities	1.070M	2.170M	1.830M
Net Change In Cash	11.51M	26.46M	-2.190M
YoY Change	-56.5%	33.84%	-97.58%
FREE CASH FLOW
Cash From Operating Activities	$17.35M	$16.06M	$2.820M
Capital Expenditures	-$4.880M	-$8.150M	-$9.610M
Free Cash Flow	$22.23M	$24.21M	$12.43M
YoY Change	-8.18%	-372.51%	-10.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37525108	shares
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2016Q2	dei	Entity Public Float EntityPublicFloat	949000000	USD
CY2016	dei	Entity Registrant Name EntityRegistrantName	Pacira Pharmaceuticals, Inc.
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2015Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	1605000	USD
CY2016Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	1605000	USD
CY2015Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	14601000	USD
CY2016Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	16538000	USD
CY2014Q4	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	487000	USD
CY2015	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	481000	USD
CY2016	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	479000	USD
CY2016	pcrx	Beginning Period Prior To Product Expiration Allowed For Returning Product BeginningPeriodPriorToProductExpirationAllowedForReturningProduct	P6M
CY2014Q4	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	1287000	USD
CY2015	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	1426000	USD
CY2016	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	3426000	USD
CY2014Q4	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	345000	USD
CY2015	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	852000	USD
CY2016	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	785000	USD
CY2014Q4	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	19182000	USD
CY2015	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	27262000	USD
CY2016	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	24505000	USD
CY2014Q4	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	5295000	USD
CY2015	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	2367000	USD
CY2016	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	841000	USD
CY2012Q2	pcrx	Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition	2000000	USD
CY2016Q4	pcrx	Contract Termination Fee ContractTerminationFee	7100000	USD
CY2016Q4	pcrx	Contract Termination Fee Current Portion ContractTerminationFeeCurrentPortion	5300000	USD
CY2016Q4	pcrx	Contract Termination Fee Long Term Portion ContractTerminationFeeLongTermPortion	1800000	USD
CY2016Q4	pcrx	Conversion Request Convertible Senior Notes ConversionRequestConvertibleSeniorNotes	1500000	USD
CY2016	pcrx	Debt Instrument Convertible Conversion Premium Shares DebtInstrumentConvertibleConversionPremiumShares	1100000.0	shares
CY2016Q4	pcrx	Debt Instrument Convertible Conversion Value DebtInstrumentConvertibleConversionValue	35700000	USD
CY2015Q4	pcrx	Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance	132116000	USD
CY2016Q4	pcrx	Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance	148753000	USD
CY2015Q4	pcrx	Deferred Tax Assets Stock Based Compensation DeferredTaxAssetsStockBasedCompensation	17201000	USD
CY2016Q4	pcrx	Deferred Tax Assets Stock Based Compensation DeferredTaxAssetsStockBasedCompensation	21890000	USD
CY2014	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.0013
CY2015	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	0.1203
CY2016	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.0081
CY2014	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	0.1068
CY2015	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	-0.3757
CY2016	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	0.0575
CY2014	pcrx	Effectofstateblendedtaxratechanges Effectofstateblendedtaxratechanges	0.0000
CY2015	pcrx	Effectofstateblendedtaxratechanges Effectofstateblendedtaxratechanges	0.0000
CY2016	pcrx	Effectofstateblendedtaxratechanges Effectofstateblendedtaxratechanges	-0.0465
CY2016Q4	pcrx	Employee Stock Purchase Plan Espp Sharesin Espp EmployeeStockPurchasePlanESPPSharesinESPP	500000	shares
CY2016	pcrx	Employee Stock Purchase Plan Numberof Shares Authorized EmployeeStockPurchasePlanNumberofSharesAuthorized	500000	shares
CY2016	pcrx	Employee Stock Purchase Plan Numberof Shares Available For Purchase EmployeeStockPurchasePlanNumberofSharesAvailableForPurchase	396380	shares
CY2016Q4	pcrx	Employee Stock Purchase Planfairvalue EmployeeStockPurchasePlanfairvalue	0.85
CY2014Q4	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
CY2015	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	3929000	USD
CY2016	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
CY2015Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	25900000	USD
CY2016Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	33700000	USD
CY2016	pcrx	Goodwill Recordedfor Earn Out Payments GoodwillRecordedforEarnOutPayments	7857000	USD
CY2015	pcrx	Goodwill Recordedon Milestone Payments GoodwillRecordedonMilestonePayments	7119000	USD
CY2016	pcrx	Goodwill Recordedon Milestone Payments GoodwillRecordedonMilestonePayments	8000000	USD
CY2014Q4	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-13543000	USD
CY2015	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	2120000	USD
CY2016	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-37844000	USD
CY2014	pcrx	Income Tax Provision IncomeTaxProvision	200000	USD
CY2015	pcrx	Income Tax Provision IncomeTaxProvision	300000	USD
CY2016	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
CY2014Q4	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	970000	USD
CY2015	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	276000	USD
CY2016	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	0	USD
CY2014Q4	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	0	shares
CY2015	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	3000	shares
CY2016	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	0	shares
CY2016Q4	pcrx	Maximum Fair Market Value Purchaseof Espp Shares MaximumFairMarketValuePurchaseofESPPShares	25000	USD
CY2016	pcrx	Minimum Cumulative Percentage Of Change In Ownership As Condition To Offset Taxable Income Or Tax MinimumCumulativePercentageOfChangeInOwnershipAsConditionToOffsetTaxableIncomeOrTax	0.5
CY2016Q4	pcrx	Non Us Net Operating Loss NonUSNetOperatingLoss	3400000	USD
CY2015	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2016	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2016Q4	pcrx	Operating Loss Carryforwards Related To Stock Based Compensation OperatingLossCarryforwardsRelatedToStockBasedCompensation	78200000	USD
CY2012Q2	pcrx	Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition	10000000	USD
CY2014Q4	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	13433000	USD
CY2015	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	7119000	USD
CY2016	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	15857000	USD
CY2016	pcrx	Period After Product Expiration Upto Which Product Is Allowed To Be Returned PeriodAfterProductExpirationUptoWhichProductIsAllowedToBeReturned	P12M
CY2014Q4	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	1184000	USD
CY2015Q4	pcrx	Product Returns Rebatesand Other Fees ProductReturnsRebatesandOtherFees	3494000	USD
CY2016Q4	pcrx	Product Returns Rebatesand Other Fees ProductReturnsRebatesandOtherFees	3473000	USD
CY2015	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	2093000	USD
CY2016	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	1495000	USD
CY2016	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2016Q4	pcrx	Sharebased Compensationarrangementby Sharebasedpaymentawardequityinstrumentsothersthanoptionsvestedandexpectedtovestweightedaveragegrantdatefairvalue SharebasedCompensationarrangementbySharebasedpaymentawardequityinstrumentsothersthanoptionsvestedandexpectedtovestweightedaveragegrantdatefairvalue	53.05
CY2016Q4	pcrx	Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestaggregateintrinsicvalue Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestaggregateintrinsicvalue	9974000	USD
CY2016	pcrx	Stock Issued During Period Convertible Senior Notes Conversion StockIssuedDuringPeriodConvertibleSeniorNotesConversion	44287	shares
CY2014Q4	pcrx	Stock Issued During Period Proceeds Followon Public Offering Issues StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues	110452000	USD
CY2015	pcrx	Stock Issued During Period Proceeds Followon Public Offering Issues StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues	0	USD
CY2016	pcrx	Stock Issued During Period Proceeds Followon Public Offering Issues StockIssuedDuringPeriodProceedsFollowonPublicOfferingIssues	0	USD
CY2016Q4	pcrx	Total Goodwill Recordedfor Earn Out Payments TotalGoodwillRecordedforEarnOutPayments	22800000	USD
CY2014	pcrx	United States Statutory Tax Rate UnitedStatesStatutoryTaxRate	0.35
CY2015	pcrx	United States Statutory Tax Rate UnitedStatesStatutoryTaxRate	0.35
CY2016	pcrx	United States Statutory Tax Rate UnitedStatesStatutoryTaxRate	0.35
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8739000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7511000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25855000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29937000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35375000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	36666000	USD
CY2015Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3731000	USD
CY2016Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3822000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24917000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	37510000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-52000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-30000	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	526696000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	565207000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-4100000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-2000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24822000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	33368000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	31248000	USD
CY2014Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24822000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33368000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31248000	USD
CY2014Q4	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4139000	USD
CY2015	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4102000	USD
CY2016	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4088000	USD
CY2014Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2014Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6039000	shares
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1998000	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6816000	shares
CY2015Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	600000	USD
CY2016Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	500000	USD
CY2015Q4	us-gaap	Assets Assets	387735000	USD
CY2016Q4	us-gaap	Assets Assets	391466000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	252582000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	243089000	USD
CY2015Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	115495000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	136683000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	33000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	19000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	85000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	49000	USD
CY2014Q4	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	-1095000	USD
CY2015	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1393000	USD
CY2016	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	-789000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12515000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37520000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56984000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35944000	USD
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	13.44
CY2012Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	162885	shares
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	7216	shares
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	36848319	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37480952	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36848319	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37480952	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	37000	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	37000	USD
CY2014Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13801000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1884000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37927000	USD
CY2015Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	104040000	USD
CY2016Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2015Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	USD
CY2016Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	108738000	USD
CY2014Q4	us-gaap	Cost Of Revenue CostOfRevenue	77440000	USD
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	17580000	USD
CY2015Q2	us-gaap	Cost Of Revenue CostOfRevenue	18929000	USD
CY2015Q3	us-gaap	Cost Of Revenue CostOfRevenue	15901000	USD
CY2015Q4	us-gaap	Cost Of Revenue CostOfRevenue	19427000	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	71837000	USD
CY2016Q1	us-gaap	Cost Of Revenue CostOfRevenue	20278000	USD
CY2016Q2	us-gaap	Cost Of Revenue CostOfRevenue	23053000	USD
CY2016Q3	us-gaap	Cost Of Revenue CostOfRevenue	43152000	USD
CY2016Q4	us-gaap	Cost Of Revenue CostOfRevenue	23621000	USD
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	110104000	USD
CY2014Q4	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	92000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	11000	USD
CY2014Q4	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	173000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	172000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	94000	USD
CY2016Q4	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1100000	shares
CY2015Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	12605000	USD
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	8517000	USD
CY2015Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1888000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1276000	USD
CY2015Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	9200000	USD
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	8600000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1426000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	595000	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	8082000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	7487000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	3530000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	3023000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	136795000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	151939000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	101011000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	96163000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	953000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	531000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1310000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2604000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	7232000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	13724000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	5558000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	14004000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	132116000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	148753000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	4679000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	3186000	USD
CY2014Q4	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1000000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1700000	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1500000	USD
CY2014Q4	us-gaap	Depreciation Depreciation	9300000	USD
CY2015	us-gaap	Depreciation Depreciation	11200000	USD
CY2016	us-gaap	Depreciation Depreciation	12800000	USD
CY2014Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10035000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11475000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12919000	USD
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.02
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.03
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.00
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.08
CY2015Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.59
CY2016Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.02
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0128
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.1245
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0028
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1771
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1032
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.4396
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0044
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0726
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0054
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0155
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.1533
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0204
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.3262
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0071
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0220
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0549
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.3063
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0877
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	11944000	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	11228000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14919000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	81000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	USD
CY2014Q4	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-158000	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-6000	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-389000	USD
CY2014Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-52000	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2014Q4	us-gaap	Goodwill Goodwill	23761000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	30880000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	46737000	USD
CY2012Q2	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	8000000	USD
CY2016Q4	us-gaap	Incentive From Lessor IncentiveFromLessor	5600000	USD
CY2014Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-13271000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	3760000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-36339000	USD
CY2014Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13543000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2120000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37844000	USD
CY2014Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-272000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1640000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1505000	USD
CY2014Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	173000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	264000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	105000	USD
CY2014Q4	us-gaap	Income Taxes Paid IncomeTaxesPaid	34000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	195000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	247000	USD
CY2014Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	15349000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8966000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	710000	USD
CY2014Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7776000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3489000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4082000	USD
CY2014Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	6713000	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1426000	USD
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1426000	USD
CY2014Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13706000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	32382000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-30367000	USD
CY2014Q4	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2526000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	5786000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	87000	USD
CY2014Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1621000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2007000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3377000	USD
CY2014Q4	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-124000	USD
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1509000	USD
CY2016	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2014Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6000	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2014Q4	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3113000	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2014Q4	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	1000	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2014Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1638000	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2014Q4	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000	USD
CY2015	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	800000	USD
CY2016	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1500000	USD
CY2014Q4	us-gaap	Interest Expense InterestExpense	8278000	USD
CY2015	us-gaap	Interest Expense InterestExpense	7725000	USD
CY2016	us-gaap	Interest Expense InterestExpense	7061000	USD
CY2014Q4	us-gaap	Interest Paid InterestPaid	5193000	USD
CY2015	us-gaap	Interest Paid InterestPaid	4224000	USD
CY2016	us-gaap	Interest Paid InterestPaid	3852000	USD
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	32781000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7915000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	61645000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	31278000	USD
CY2015Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16712000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	11742000	USD
CY2015Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	12152000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	11621000	USD
CY2014Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	382000	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	678000	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	1323000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	169343000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	172490000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	387735000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	391466000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	149788000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	44838000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	104040000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	108738000	USD
CY2015Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	118533000	USD
CY2016Q4	us-gaap	Long Term Investments LongTermInvestments	0	USD
CY2014Q4	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	25005000	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	118531000	USD
CY2015Q4	us-gaap	Long Term Investments LongTermInvestments	13462000	USD
CY2015	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	19464000	USD
CY2016	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-21040000	USD
CY2014Q4	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	118875000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	10699000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	7261000	USD
CY2014Q4	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-120434000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-19256000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-61754000	USD
CY2014Q4	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	26564000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	28021000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	33453000	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	-13716000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-13716000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	1260000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	8000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	3086000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-2498000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	1856000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-3854000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-7958000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-22164000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-3973000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-37949000	USD
CY2014Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8378000	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7335000	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5820000	USD
CY2016	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2014Q4	us-gaap	Operating Expenses OperatingExpenses	202833000	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	54975000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	57330000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	57104000	USD
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	70133000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	239542000	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	67728000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	76084000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	89220000	USD
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	75363000	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	308395000	USD
CY2014Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-5165000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	9455000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-32024000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	39356000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	7880000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1207000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	6389000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	8272000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	8063000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	7545000	USD
CY2014Q4	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	4900000	USD
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	5700000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	6000000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	406000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	624000	USD
CY2014Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-85000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	28000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	22000	USD
CY2014Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-85000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-85000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	28000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	22000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11473000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11427000	USD
CY2014Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-159000	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-165000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-82000	USD
CY2014Q4	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	164303000	USD
CY2015	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	189082000	USD
CY2016	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	192815000	USD
CY2014Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22984000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	40295000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24709000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6117000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9277000	USD
CY2014Q2	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	110500000	USD
CY2015	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	-1467000	USD
CY2016	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	-4000	USD
CY2014Q4	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	80286000	USD
CY2015	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	217240000	USD
CY2016	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	171627000	USD
CY2014Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7239000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10073000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5770000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	115241000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	138526000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	90324000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101016000	USD
CY2016Q4	us-gaap	Purchase Obligation PurchaseObligation	600000	USD
CY2014Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18731000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28662000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45678000	USD
CY2014Q4	us-gaap	Restricted Stock Expense RestrictedStockExpense	0	USD
CY2015	us-gaap	Restricted Stock Expense RestrictedStockExpense	2887000	USD
CY2016	us-gaap	Restricted Stock Expense RestrictedStockExpense	5117000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-308289000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-346238000	USD
CY2014Q4	us-gaap	Revenues Revenues	197668000	USD
CY2015Q1	us-gaap	Revenues Revenues	58316000	USD
CY2015Q2	us-gaap	Revenues Revenues	59148000	USD
CY2015Q3	us-gaap	Revenues Revenues	62213000	USD
CY2015Q4	us-gaap	Revenues Revenues	69320000	USD
CY2015	us-gaap	Revenues Revenues	248997000	USD
CY2016Q1	us-gaap	Revenues Revenues	65474000	USD
CY2016Q2	us-gaap	Revenues Revenues	69640000	USD
CY2016Q3	us-gaap	Revenues Revenues	68355000	USD
CY2016Q4	us-gaap	Revenues Revenues	72902000	USD
CY2016	us-gaap	Revenues Revenues	276371000	USD
CY2014Q4	us-gaap	Royalty Expense RoyaltyExpense	323000	USD
CY2015	us-gaap	Royalty Expense RoyaltyExpense	71000	USD
CY2016	us-gaap	Royalty Expense RoyaltyExpense	0	USD
CY2014Q4	us-gaap	Royalty Revenue RoyaltyRevenue	2855000	USD
CY2015	us-gaap	Royalty Revenue RoyaltyRevenue	3084000	USD
CY2016	us-gaap	Royalty Revenue RoyaltyRevenue	2872000	USD
CY2014Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	193526000	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	244487000	USD
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	270073000	USD
CY2014Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	106662000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	139043000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	152613000	USD
CY2014Q4	us-gaap	Share Based Compensation ShareBasedCompensation	24822000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	33368000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	31248000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	4000000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	12129537	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3536738	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	8592799	shares
CY2016Q4	us-gaap	Share Price SharePrice	32.30
CY2014Q2	us-gaap	Share Price SharePrice	64.00
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	USD
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	16602000	USD
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	11824000	USD
CY2015Q4	us-gaap	Short Term Investments ShortTermInvestments	101981000	USD
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	136653000	USD
CY2016	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	103620	shares
CY2014Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1840000	shares
CY2015	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3929000	USD
CY2014	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1184000	USD
CY2015	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2093000	USD
CY2016	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1495000	USD
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	110452000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2014	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7239000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10073000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5770000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	41249000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	171145000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	218392000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	218976000	USD
CY2015Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	208000	USD
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	66000	USD
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2014Q4	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	9900000	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	800000	USD
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	16600000	USD
CY2014	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	8323000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	10746000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	12871000	USD
CY2013Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	1878000	USD
CY2014Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3043000	USD
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3900000	USD
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3800000	USD
CY2014	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	7158000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	9889000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	12971000	USD
CY2014Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35299000	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41301000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37236000	shares
CY2014Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	35299000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36540000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37236000	shares
CY2016	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2015, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2015-03, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs</font><font style="font-family:inherit;font-size:10pt;">, which requires debt issuance costs related to a recognized debt liability be presented on the balance sheet as a direct deduction from the carrying amount of the related debt liability instead of being presented as an asset. Debt disclosures will include the face amount of the debt liability and the effective interest rate. The update requires retrospective application and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15, 2015. The Company adopted this standard on January 1, 2016. The Company applied the new guidance retrospectively to all prior periods presented in the financial statements to conform to the 2016 presentation. As a result, </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;"> of debt issuance costs related to the Company’s convertible senior notes at December 31, 2015 were reclassified from other assets to a reduction in the carrying value of the Company’s convertible senior notes. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Not Adopted as of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, which requires that an entity recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to its customers. In order to achieve this core principle, an entity should apply the following steps: (1) identify the contract(s) with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation. During the fiscal third quarter of 2015, the FASB approved a one year deferral to the effective date to be adopted by all public companies for all annual periods and interim reporting periods beginning after December 15, 2017. During 2016, the FASB issued additional guidance and clarification relating to identifying performance obligations, licensing, principal versus agent considerations, assessing collectability, presentation of sales taxes, noncash consideration and contract modifications and completed contracts at transition. These updates will replace existing revenue recognition guidance under GAAP when it becomes effective for the Company beginning January 1, 2018, and permits two methods of adoption: the full retrospective method, which requires the standard to be applied to each prior period presented, or the modified retrospective method, which requires the cumulative effect of adoption to be recognized as an adjustment to opening retained earnings in the period of adoption. While the Company is continuing to evaluate the impact of these updates on its consolidated financial statements, it does not expect the implementation of ASU 2014-09 and the subsequently issued related guidance to have a material impact on its consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2015, the FASB issued ASU 2015-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventory (Topic 330): Simplifying the Measurement of Inventory</font><font style="font-family:inherit;font-size:10pt;">. The standard requires entities to measure most inventory “at the lower of cost and net realizable value,” thereby simplifying the current guidance under which an entity must measure inventory at the lower of cost or market (market in this context is defined as one of three different measures, one of which is net realizable value). The standard is effective for the Company prospectively beginning January 1, 2017. The adoption of ASU 2015-11 is not expected to have a material impact on the Company’s consolidated financial statements.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (ASC 842)</font><font style="font-family:inherit;font-size:10pt;">. This update requires lessees to recognize lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under previous authoritative guidance. The lease liability will be equal to the present value of lease payments and the right-of-use asset will be based on the lease liability, subject to adjustment for items such as initial direct costs. For income statement purposes, the new standard retains a dual model similar to Accounting Standards Codification, or ASC, 840, requiring leases to be classified as either operating or financing. For lessees, operating leases will result in straight-line expense (similar to current accounting by lessees for operating leases under ASC 840) while financing leases will result in a front-loaded expense pattern (similar to current accounting by lessees for capital leases under ASC 840). This update also introduces new disclosure requirements for leasing arrangements. The standard is effective for annual reporting periods beginning after December 15, 2018 and interim periods within those annual periods. Early adoption is permitted. The Company is evaluating the impact of ASU 2016-02 on its consolidated financial statements. Refer to Note 17, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Commitments and Contingencies</font><font style="font-family:inherit;font-size:10pt;">, for further discussion on the Company’s leases.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the FASB issued ASU 2016-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting</font><font style="font-family:inherit;font-size:10pt;">. This update includes multiple provisions intended to simplify various aspects of the accounting for share-based payment transactions including accounting for excess tax benefits and tax deficiencies, classification of excess tax benefits in the statement of cash flows and accounting for award forfeitures. The update also removes the present requirement to delay recognition of an excess tax benefit until it reduces current taxes payable, instead, it is required to be recognized at the time of settlement, subject to normal valuation allowance considerations. This update became effective for the Company beginning January 1, 2017. The Company will elect an accounting policy change to record forfeitures as they occur rather than estimating forfeitures during each period and will record a charge of approximately </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> to retained earnings as of January 1, 2017 related to the reversal of cumulative forfeiture estimates. The adoption of this standard also will result in the recognition of </font><font style="font-family:inherit;font-size:10pt;">$29.3 million</font><font style="font-family:inherit;font-size:10pt;"> of previously unrecognized excess tax benefits in deferred tax assets, fully offset by a valuation allowance. All tax-related cash flows resulting from stock-based compensation, including the excess tax benefits related to the settlement of stock-based awards, will be classified as cash flows from operating activities on the Company’s consolidated statements of cash flows. Based on a preliminary assessment, the Company does not believe that any of the provisions in ASU 2016-09 will have a significant impact on its consolidated financial statements.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments—Credit Losses (Topic 326)</font><font style="font-family:inherit;font-size:10pt;">, which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. Entities will now use forward-looking information to better form their credit loss estimates. This update also requires enhanced disclosures to help financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. This ASU is effective for annual reporting periods beginning after December 15, 2019, with early adoption permitted. The Company is evaluating the impact of ASU 2016-13 on its consolidated financial statements.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued ASU 2016-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments</font><font style="font-family:inherit;font-size:10pt;">, which clarifies existing guidance on how companies present and classify certain cash receipts and cash payments in the statement of cash flows by addressing specific cash flow issues in an effort to reduce diversity in practice, including guidance on debt prepayment or extinguishment costs and contingent consideration payments made after a business combination. This update is effective for annual reporting periods beginning after December 15, 2017, with early adoption permitted. The Company is currently evaluating the impact of ASU 2016-15 on its consolidated financial statements.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or not significant to the consolidated financial statements of the Company.</font></div></div>
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, among other things, revenue recognition, inventory costs, impairments of goodwill and long-lived assets, liabilities and accruals, stock-based compensation and the valuation of deferred tax assets. The Company’s critical accounting policies are those that are both most important to the Company’s consolidated financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results could differ from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001396814-17-000009-index-headers.html	Edgar Link	pending
0001396814-17-000009-index.html	Edgar Link	pending
0001396814-17-000009.txt	Edgar Link	pending
0001396814-17-000009-xbrl.zip	Edgar Link	pending
a123116colora01.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pcrx-12312016x10k.htm	Edgar Link	pending
pcrx-12312016xex211.htm	Edgar Link	pending
pcrx-12312016xex231.htm	Edgar Link	pending
pcrx-12312016xex232.htm	Edgar Link	pending
pcrx-12312016xex311.htm	Edgar Link	pending
pcrx-12312016xex312.htm	Edgar Link	pending
pcrx-12312016xex321.htm	Edgar Link	pending
pcrx-12312016xex322.htm	Edgar Link	pending
pcrx-20161231.xml	Edgar Link	completed
pcrx-20161231.xsd	Edgar Link	pending
pcrx-20161231_cal.xml	Edgar Link	unprocessable
pcrx-20161231_def.xml	Edgar Link	unprocessable
pcrx-20161231_lab.xml	Edgar Link	unprocessable
pcrx-20161231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2016 Q4 Form 10-K Financial Statement

#000139681417000009 Filed on March 01, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2016 Q4 Form 10-K Financial Statement

#000139681417000009 Filed on March 01, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx